Pioglitazone and lung cancer risk in Taiwanese patients with type 2 diabetes.

Diabetes Metab

Department of Internal Medicine, National Taiwan University, College of Medicine, Taipei, Taiwan; Division of Endocrinology and Metabolism, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Division of Environmental Health and Occupational Medicine of the National Health Research Institutes, Zhunan, Taiwan. Electronic address:

Published: February 2018

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.diabet.2017.05.011	DOI Listing

Publication Analysis

pioglitazone lung

lung cancer

cancer risk

risk taiwanese

taiwanese patients

patients type

type diabetes

pioglitazone

cancer

risk

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!